BIOR Company Profile and Key Details
Biora Therapeutics, Inc.
BIOR Stock Price Chart
Stock Price Today
Biora Therapeutics, Inc. (BIOR) stock declined over -42.14%, trading at $0.22 on NASDAQ, down from the previous close of -. The stock opened at $0.38, fluctuating between $0.15 and $0.38 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.
Company Information
| Employees | 58 |
| Beta | 1.28 |
| Sales or Revenue | $4.00K |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Biora Therapeutics, Inc. (NASDAQ: BIOR) stock price is $0.22 in the last trading session. During the trading session, BIOR stock reached the peak price of $0.38 while $0.15 was the lowest point it dropped to. The percentage change in BIOR stock occurred in the recent session was -42.14% while the dollar amount for the price change in BIOR stock was -$0.16.
The NASDAQ listed BIOR is part of Biotechnology industry that operates in the broader Healthcare sector. Biora Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. George Gianakopoulos
Senior Vice President of Sales
Mr. Eric d'Esparbes
Executive Vice President & Chief Financial Officer
Dr. Sharat Singh Ph.D.
Head of Research
Eric Fox
Vice President of Fin. & Accounting & Treasurer
Dr. Paul Shabram M.B.A.
Head of Technical Operations
Ms. Robyn Hatton
Head of HR
Mr. Kevin Howe Ph.D.
Senior Vice President of Strategic Operations
Mr. Clarke Neumann J.D.
Senior Vice President, Gen. Counsel & Sec.
Mr. Troy Seelye
Chief Information Officer
Mr. Aditya P. Mohanty M.B.A.
Chief Executive Officer & Director
BIOR's closing price is 273.13% higher than its 52-week low of $0.15 where as its distance from 52-week high of $19.90 is -97.19%.
Number of BIOR employees currently stands at 58.
Official Website of BIOR is: https://www.bioratherapeutics.com
BIOR could be contacted at phone 855 293 2639 and can also be accessed through its website. BIOR operates from 4330 La Jolla Village Drive, San Diego, CA 92122, United States.
BIOR stock volume for the day was 169.45K shares. The average number of BIOR shares traded daily for last 3 months was 116.45K.
The market value of BIOR currently stands at $994.99K with its latest stock price at $0.22 and 4.52M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com